Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
企業コードCOSM
会社名Cosmos Health Inc
上場日May 19, 2010
最高経営責任者「CEO」Mr. Grigorios Siokas
従業員数149
証券種類Ordinary Share
決算期末May 19
本社所在地- -
都市- -
証券取引所NASDAQ Capital Market Consolidated
国- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コードCOSM
上場日May 19, 2010
最高経営責任者「CEO」Mr. Grigorios Siokas
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし